Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sensory neuron diseases.

Angelo Sghirlanzoni1, Davide Pareyson, Giuseppe Lauria

  • 1Neuro-Oncology Unit, National Neurological Institute Carlo Besta, Milan, Italy.

The Lancet. Neurology
|May 24, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacological Interventions for Hereditary Transthyretin-Related Amyloidosis With Polyneuropathy: Systematic Review and Network Meta-Analysis.

European journal of neurology·2026
Same author

A Quantitative Assessment of Upper Limb Motor Function Across Disease Stages in Hereditary Transthyretin Amyloidosis.

Journal of the peripheral nervous system : JPNS·2026
Same author

ChatGPT in the diagnosis and management of complex polyneuropathies: comparative analysis with neurologists using real-world cases.

NPJ digital medicine·2026
Same author

Deep Phenotyping of F64L Mutation in a Multicentric Cohort of Patisiran-Treated Hereditary Transthyretin Amyloidosis Patients (Patisiranitaly).

European journal of neurology·2026
Same author

Clinical and pathological findings in two Italian siblings of Romani ancestry with charcot-marie-tooth type 4D and review of the current literature.

Journal of neuromuscular diseases·2026
Same author

Mitochondrial energetic failure underlies FLVCR1-related sensory neuropathy.

Communications biology·2026
Same journal

Resolution of expression of concern-Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.

The Lancet. Neurology·2026
Same journal

UCL Queen Square Institute of Neurology: 75 years of innovation.

The Lancet. Neurology·2026
Same journal

Correction to Lancet Neurol 2026; 25: 631.

The Lancet. Neurology·2026
Same journal

Epstein-Barr virus and multiple sclerosis: from associations to mechanisms to potential therapies.

The Lancet. Neurology·2026
Same journal

Correction to Lancet Neurol 2025; 24: 740-52.

The Lancet. Neurology·2026
Same journal

Correction to Lancet Neurol 2026; 25: 357-67.

The Lancet. Neurology·2026
See all related articles

Sensory neuron diseases (SND) involve the loss of sensory neurons, causing unique nerve degeneration patterns. This study outlines a comprehensive diagnostic approach for both acquired and hereditary forms of SND.

Area of Science:

  • Neurology
  • Neuroscience
  • Genetics

Background:

  • Sensory neuron diseases (SND) are a subgroup of peripheral nervous system disorders.
  • SND can be acquired, linked to systemic diseases, toxins, or cancer, or hereditary.
  • Pathologically, SND involves sensory neuron loss in dorsal root ganglia, leading to axonal degeneration.

Purpose of the Study:

  • To propose a comprehensive diagnostic strategy for acquired and hereditary Sensory Neuron Diseases.
  • To detail the clinical, genetic, and pathological features of SND.
  • To enhance understanding of the diagnostic process for SND.

Main Methods:

  • Review of clinical presentations of acquired and hereditary SND.
  • Analysis of genetic factors contributing to hereditary SND.

Related Experiment Videos

  • Discussion of neurophysiological, neuroradiological, and neuropathological assessment techniques.
  • Main Results:

    • SND exhibits a unique, non-length-dependent sensory nerve degeneration pattern.
    • Acquired SND is associated with various systemic conditions and toxic exposures.
    • Hereditary SND subtypes correlate with specific clinical and genetic profiles.

    Conclusions:

    • A multi-faceted diagnostic approach integrating clinical, genetic, and pathological data is crucial for SND.
    • Understanding the distinct pathological mechanisms aids in diagnosing acquired versus hereditary SND.
    • This comprehensive strategy aims to improve the diagnosis and management of sensory neuron diseases.